Medtronic launches spinal tech; Shutdown halts NIH trial enrollment;

@FierceMedDev: Lensar hauls in $87M for laser eye surgery tech. News | Follow @FierceMedDev

@MarkHFierce: FierceDiagnostics has another great crop of stories for you. Check it out | Follow @MarkHFierce

@MichaelGFierce: ICYMI: Oral peptide delivery biz Enteris lands Nordic partnership. More from FierceDrugDelivery | Follow @MichaelGFierce

> Medtronic ($MDT) has launched its Cornerstone-SR Alliance spinal cage in Europe, marketing the device as a step forward in the treatment of disc disease. Release

> Shares of AngioDynamics ($ANGO) have jumped more than 20% since September, Forbes notes, and the New York devicemaker is primed for more success. Article

> Lombard Medical is expanding its U.K. manufacturing presence to meet increased demand for its FDA-approved Aorfix device. More

> The Washington Post's editorial board has come out against a repeal of the medical device tax, arguing that caving to the industry would only encourage other interest groups to pursue the same strategy. Column

> The ongoing government shutdown has halted clinical trial enrollment at the National Institutes of Health. Article

Biotech News

@FierceBiotech: ICYMI: Top 15 highest paid biopharma R&D chiefs. Special report | Follow @FierceBiotech

@JohnCFierce: The turnaround plan: stay put, target drugs, more deals--John Reed sets out on a long-distance run at Roche's pRED. Feature | Follow @JohnCFierce

@DamianFierce: Updated story on Frazier's $377M new fund with comments from General Partner Jamie Topper. ICYMI yesterday | Follow @DamianFierce

@EmilyMFierce: NIH Feels Multiplying Effects of Government Shutdown. Article from Scientific American | Follow @EmilyMFierce

> Analyst: More Lilly R&D failures likely to trigger 'savage cost cuts.' More

> Cancer biotech upstart nabs $33M A round for R&D work, Array collaboration. Story

> J&J makes an R&D splash with $42M venture play, biotech collaborations. Report

> Shutdown halts NIH drug trials as researchers hit brakes on preclinical research. Article

Pharma News

@FiercePharma: Funnily enough, we publish Top 15 Drug Launch Superstars, and 1000s click thru to last year's Top 10 Launch Disasters. | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Acino agrees to $439M takeover offer from private equity firms. More | Follow @CarlyHFierce

> Lilly warns of 'challenging' bid for 2014 sales goal, thanks to yen, emerging markets. News

> Novartis, Sanofi, Biogen tout new MS drug research. Story

Vaccines News

> NIH expands vaccine clinical trial network. Item

> CDC reports across-the-board rises in flu vaccine uptake. Report

> Researchers highlight knowledge gaps hindering cancer vaccines. Story

> Vaccines spared as Merck takes ax to R&D. More

> Government shutdown forces CDC to halt seasonal flu program. Article

Pharma Manufacturing News

@EricPFierce: Hospira faces more vial problems. FDA and co. say glass strands pose potential health threat. More | Follow @EricPFierce

> Ranbaxy denies FDA issues will lead to layoffs. Item

> SCM offers 'blank canvas' to sterile injectable clients. Story

> FDA threatens drugmaker with ban for not paying user fee. Article

> CML, AAIPharma join forces to create CMC specialist. More

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.